Table 2.

Detailed statistics of expression of VDR, CYP27B and SNHG6, SNHG16, Linc00511 and Linc00346 lncRNAs in COVID-19 patients and controls (RME: Ratio of mean expression)

		SNHG6					SNHG16					VDR					Linc00511					Linc00346					CYP27B
Number of Samples		SE	RME	P Value	95% CI		SE	RME	P Value	95% CI		SE	RME	P Value	95% CI		SE	RME	P Value	95% CI		SE	RME	P Value	95% CI		SE	RME	P Value	95% CI
Cases/ controls
Total	91/91	0.54	0.22	0.00	−3.29	−1.14	0.56	0.20	0.00	−3.40	− 1.20	0.61	0.42	0.04	−2.44	−0.05	0.64	1.55	0.33	−0.64	1.90	0.62	1.34	0.50	−0.80	1.64	0.61	0.71	0.43	−1.69	0.72
F	38/39	0.78	0.32	0.04	−3.21	−0.09	0.79	0.32	0.04	−3.22	−0.05	0.89	0.78	0.68	−2.14	1.41	0.86	1.01	0.99	−1.71	1.74	0.98	1.98	0.32	−0.96	2.93	0.79	1.39	0.54	−1.09	2.04
M	53/52	0.75	0.16	0.00	−4.11	−1.14	0.78	0.14	0.00	−4.33	−1.25	0.82	0.27	0.02	−3.51	−0.25	0.92	2.11	0.25	−0.75	2.90	0.81	1.01	0.99	−1.59	1.61	0.88	0.43	0.17	−2.96	0.53
ICU/ Non-ICU
Total	37/54	0.75	1.74	0.29	−0.69	2.30	0.75	1.49	0.44	−0.91	2.06	0.84	0.90	0.85	−1.82	1.51	0.87	0.60	0.40	−2.47	0.99	0.84	0.73	0.59	−2.12	1.21	0.85	0.79	0.68	−2.03	1.34
F	13/25	0.97	2.18	0.26	−0.85	3.10	1.09	1.11	0.90	−2.12	2.41	1.29	0.90	0.91	−2.78	2.48	1.01	0.62	0.51	−2.74	1.38	1.46	0.59	0.61	−3.77	2.25	1.03	0.92	0.91	−2.22	1.99
M	24/29	1.10	1.64	0.52	−1.49	2.92	1.04	1.93	0.37	−1.14	3.04	1.12	1.05	0.95	−2.18	2.33	1.27	0.52	0.46	−3.50	1.61	1.03	0.90	0.88	−2.23	1.92	1.23	0.71	0.69	−2.98	1.98